-
Je něco špatně v tomto záznamu ?
Influenza and pneumococcal vaccination in older adults living in nursing home: a survival analysis on the shelter study
A. Poscia, A. Collamati, A. Carfì, E. Topinkova, T. Richter, M. Denkinger, R. Pastorino, F. Landi, W. Ricciardi, R. Bernabei, G. Onder,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Open Access Digital Library od 1996-01-01
CINAHL Plus with Full Text (EBSCOhost) od 2006-01-02
Oxford Journals Open Access Collection od 1991-01-01
Odkazy
PubMed
29069321
DOI
10.1093/eurpub/ckx150
Knihovny.cz E-zdroje
- MeSH
- analýza přežití MeSH
- křehký senior statistika a číselné údaje MeSH
- lidé MeSH
- mortalita MeSH
- pečovatelské domovy statistika a číselné údaje MeSH
- pneumokokové vakcíny terapeutické užití MeSH
- proporcionální rizikové modely MeSH
- senioři nad 80 let MeSH
- vakcíny proti chřipce terapeutické užití MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
Background: Influenza and pneumococcal vaccines have been proved to be effective and safe in preventing and controlling infection among elderly, reducing morbidity and mortality. However, some evidences raised health concerns related to these vaccinations. This study aims to identify prevalence and outcomes related to influenza and pneumococcal vaccinations in a large European population of frail old people living in nursing homes (NHs). Methods: We conducted a survival analysis of NH residents participating to the Services and Health for Elderly in Long-TERm project, a prospective cohort study collecting information on residents admitted to 57 NH in eight countries (Czech Republic, England, Finland, France, Germany, Italy, The Netherlands and Israel). Clinical and demographical data were collected using the international resident assessement instrument for long-term care facilities. Incident mortality was recorded during 1-year follow-up. A shared-frailty Cox regression model was used to assess the impact of vaccination status on mortality. Results: Mean age of 3510 participants was 84.6 years (SD = 7.7). In total, 81.7 and 27.0% received influenza and pneumococcal vaccination, respectively. Overall, 727 (20.7%) residents died during the follow-up period. After adjusting for potential confounders, which included age, sex, number of diseases, depression, cognitive and functional status, influenza (HR = 0.80; 95% CI 0.66-0.97) and the combination of influenza and pneumococcal vaccination (HR = 0.72; 95% CI 0.57-0.91), but not pneumococcal vaccination alone (HR = 0.52; 95% CI 0.25-1.06), were associated with a statistically significant reduction in mortality in respect of no vaccinations. Conclusion: In a population of older adult living in NH influenza and the combination of influenza and pneumococcal vaccination were associated with a reduction in all-cause mortality respect to no vaccination.
Department of Geriatrics 1st Faculty of Medicine Charles University Prague Czech Republic
GAPLESION Bethesda Clinic Competence Centre of Geriatrics University of Ulm Ulm Germany
Institute of Public Health Università Cattolica del Sacro Cuore of Rome Rome Italy
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024533
- 003
- CZ-PrNML
- 005
- 20180713114329.0
- 007
- ta
- 008
- 180709s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/eurpub/ckx150 $2 doi
- 035 __
- $a (PubMed)29069321
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Poscia, Andrea $u Institute of Public Health, Università Cattolica del Sacro Cuore of Rome, Rome, Italy.
- 245 10
- $a Influenza and pneumococcal vaccination in older adults living in nursing home: a survival analysis on the shelter study / $c A. Poscia, A. Collamati, A. Carfì, E. Topinkova, T. Richter, M. Denkinger, R. Pastorino, F. Landi, W. Ricciardi, R. Bernabei, G. Onder,
- 520 9_
- $a Background: Influenza and pneumococcal vaccines have been proved to be effective and safe in preventing and controlling infection among elderly, reducing morbidity and mortality. However, some evidences raised health concerns related to these vaccinations. This study aims to identify prevalence and outcomes related to influenza and pneumococcal vaccinations in a large European population of frail old people living in nursing homes (NHs). Methods: We conducted a survival analysis of NH residents participating to the Services and Health for Elderly in Long-TERm project, a prospective cohort study collecting information on residents admitted to 57 NH in eight countries (Czech Republic, England, Finland, France, Germany, Italy, The Netherlands and Israel). Clinical and demographical data were collected using the international resident assessement instrument for long-term care facilities. Incident mortality was recorded during 1-year follow-up. A shared-frailty Cox regression model was used to assess the impact of vaccination status on mortality. Results: Mean age of 3510 participants was 84.6 years (SD = 7.7). In total, 81.7 and 27.0% received influenza and pneumococcal vaccination, respectively. Overall, 727 (20.7%) residents died during the follow-up period. After adjusting for potential confounders, which included age, sex, number of diseases, depression, cognitive and functional status, influenza (HR = 0.80; 95% CI 0.66-0.97) and the combination of influenza and pneumococcal vaccination (HR = 0.72; 95% CI 0.57-0.91), but not pneumococcal vaccination alone (HR = 0.52; 95% CI 0.25-1.06), were associated with a statistically significant reduction in mortality in respect of no vaccinations. Conclusion: In a population of older adult living in NH influenza and the combination of influenza and pneumococcal vaccination were associated with a reduction in all-cause mortality respect to no vaccination.
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a Evropa $x epidemiologie $7 D005060
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a křehký senior $x statistika a číselné údaje $7 D016330
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vakcíny proti chřipce $x terapeutické užití $7 D007252
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mortalita $7 D009026
- 650 _2
- $a pečovatelské domovy $x statistika a číselné údaje $7 D009735
- 650 _2
- $a pneumokokové vakcíny $x terapeutické užití $7 D022242
- 650 _2
- $a proporcionální rizikové modely $7 D016016
- 650 _2
- $a analýza přežití $7 D016019
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Collamati, Agnese $u Department of Geriatrics, Neurosciences, and Orthopedics, Università Cattolica del Sacro Cuore of Rome, Rome, Italy.
- 700 1_
- $a Carfì, Angelo $u Department of Geriatrics, Neurosciences, and Orthopedics, Università Cattolica del Sacro Cuore of Rome, Rome, Italy.
- 700 1_
- $a Topinkova, Eva $u Department of Geriatrics, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Richter, Tomas $u Department of Geriatrics, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Denkinger, Michael $u GAPLESION Bethesda Clinic, Competence Centre of Geriatrics, University of Ulm, Ulm, Germany.
- 700 1_
- $a Pastorino, Roberta $u Institute of Public Health, Università Cattolica del Sacro Cuore of Rome, Rome, Italy.
- 700 1_
- $a Landi, Francesco $u Department of Geriatrics, Neurosciences, and Orthopedics, Università Cattolica del Sacro Cuore of Rome, Rome, Italy.
- 700 1_
- $a Ricciardi, Walter $u Institute of Public Health, Università Cattolica del Sacro Cuore of Rome, Rome, Italy. National Institute of Health, Rome, Italy.
- 700 1_
- $a Bernabei, Roberto $u Department of Geriatrics, Neurosciences, and Orthopedics, Università Cattolica del Sacro Cuore of Rome, Rome, Italy.
- 700 1_
- $a Onder, Graziano $u Department of Geriatrics, Neurosciences, and Orthopedics, Università Cattolica del Sacro Cuore of Rome, Rome, Italy.
- 773 0_
- $w MED00012099 $t European journal of public health $x 1464-360X $g Roč. 27, č. 6 (2017), s. 1016-1020
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29069321 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180713114623 $b ABA008
- 999 __
- $a ok $b bmc $g 1316664 $s 1021454
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 27 $c 6 $d 1016-1020 $i 1464-360X $m European journal of public health $n Eur J Public Health $x MED00012099
- LZP __
- $a Pubmed-20180709